Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...

Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Evommune, Inc. (NYSE: EVMN) (the "Company" or "Evommune"), a clinical-stage biotechnology company developing innovative ...

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...

In adolescents, the most common adverse events (occurring in =5% of ML-004-treated adolescents and at least twice the rate of placebo) were headache (13.7% vs. 3.9%), somnolence (11.8% vs. 0%), nausea ...

JUST COMING DOWN TO COST. THAT’S RIGHT. THEY SAID NEGOTIATIONS BROKE DOWN AND THEY JUST COULDN’T SEE EYE TO EYE WITH KIEWIT. WHEN IT COMES TO PHASE TWO OF THE PROJECT. IT’S ALL ABOUT THE NEGOTIATIONS ...

Officials in Maryland said Tuesday that estimates provided by a contractor to rebuild the Francis Scott Key Bridge were too high and that the state will reopen the bidding process for the next phase ...

Abstract: This paper investigates Binary-Phase Shift Keying (BPSK) based Time-Domain Single Carrier Index Modulation (TDSC-IM) optical signaling for next generation very high speed Passive Optical ...